Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Vasculitis
ADR ID BADD_A04537
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.02      Vasculitides
10.02.02.006      Vasculitis
24      Vascular disorders
24.12      Vascular infections and inflammations
24.12.04      Vasculitides NEC
24.12.04.027      Vasculitis
Description A disorder characterized by inflammation involving the wall of a vessel. [CTCAE] Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. [MeSH]
MedDRA Code 10047115
MeSH ID D014657
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Angiitis | Digital vasculitis | Focal vasculitis | Panagiitis | Polyangiitis | Vasculitis | Vasculitis aggravated | Vasculitis legs | Vasculitis NOS | Vasculitis NOS aggravated | Vasculitis worsened | Granulomatous vasculitis | Ischaemic vasculitis | Ischemic vasculitis | Vasculitides | Angiitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00537Cromoglycate--
BADD_D00549Cyclophosphamide--
BADD_D00551Cyclosporine0.000111%
BADD_D00563Dabigatran0.002642%
BADD_D00564Dabigatran etexilate--
BADD_D00566Dabrafenib0.000112%
BADD_D00570Daclizumab--
BADD_D00581Daptomycin0.000097%
BADD_D00586Darunavir0.002984%
BADD_D00594Deferasirox0.003346%
BADD_D00623Dexamethasone0.000145%
BADD_D00624Dexamethasone phosphate--
BADD_D00655Diclofenac potassium--
BADD_D00656Diclofenac sodium--
BADD_D00674Diltiazem--
BADD_D00730Dronedarone--
BADD_D00765Empagliflozin0.000400%
BADD_D00767Enalapril maleate--
BADD_D00768Enalaprilat--
BADD_D00802Ertapenem--
BADD_D00809Escitalopram0.000019%
BADD_D00821Estradiol--
BADD_D00850Etodolac--
BADD_D00855Etoposide phosphate--
BADD_D00858Everolimus0.000306%
BADD_D00864Ezetimibe--
BADD_D00871Felbamate--
BADD_D00912Fluconazole0.000067%
BADD_D00932Fluoxetine--
BADD_D00941Flurbiprofen--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 10 Pages
ADReCS-Target
ADR Term Drug Name Target